Mirati Therapeutics, Inc. Operating Margin 2013-2023 | MRTX
Current and historical operating margin for Mirati Therapeutics, Inc. (MRTX) over the last 10 years. The current operating profit margin for Mirati Therapeutics, Inc. as of September 30, 2023 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-09-30 | $0.04B | $-0.77B | -2013.16% |
| 2023-06-30 | $0.03B | $-0.78B | -2885.19% |
| 2023-03-31 | $0.02B | $-0.77B | -4272.22% |
| 2022-12-31 | $0.01B | $-0.76B | -6325.00% |
| 2022-09-30 | $0.01B | $-0.74B | -6763.64% |
| 2022-06-30 | $0.08B | $-0.64B | -816.67% |
| 2021-09-30 | $0.07B | $-0.48B | -650.00% |
| 2020-12-31 | $0.01B | $-0.37B | -2838.46% |
| 2020-09-30 | $0.01B | $-0.34B | -2816.67% |
| 2020-03-31 | $0.00B | $-0.27B | -8966.67% |
| 2019-12-31 | $0.00B | $-0.22B | -5575.00% |
| 2019-09-30 | $0.01B | $-0.18B | -2966.67% |
| 2018-12-31 | $0.01B | $-0.10B | -858.33% |
